Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,705.00
Bid: 1,701.00
Ask: 1,701.50
Change: 32.00 (1.91%)
Spread: 0.50 (0.029%)
Open: 1,685.50
High: 1,718.50
Low: 1,673.00
Prev. Close: 1,673.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS: Goldman Sachs Says Buy Royal Mail And Intertek

Fri, 07th Nov 2014 09:42

LONDON (Alliance News) - The following UK shares received analyst recommendations Friday morning and Thursday afternoon:
----------
FTSE 100
----------
GOLDMAN RAISES BABCOCK INTERNATIONAL PRICE TARGET TO 1438 (1380) PENCE - 'BUY'
----------
GOLDMAN RESUMES ROYAL MAIL WITH 'BUY' - TARGET 575 PENCE
----------
GOLDMAN RAISES INTERTEK TO 'BUY' ('NEUTRAL') - TARGET 3440 (3240) PENCE
----------
GOLDMAN RAISES EXPERIAN TO 'NEUTRAL' ('SELL') - TARGET 1078 (985) PENCE
----------
TRADERS: NOMURA RAISES EXPERIAN PRICE TARGET TO 1,130 (1,100) PENCE - 'BUY'
----------
UBS CUTS COCA-COLA HBC TARGET TO 1,360 (1,450) PENCE - 'NEUTRAL'
----------
Nomura Cuts Coca-Cola HBC Price Target To 1,100p From 1,140p, Maintains Reduce
----------
UBS CUTS RSA INSURANCE PRICE TARGET TO 418 (427) PENCE - 'SELL'
----------
EXANE BNP RAISES RSA INSURANCE PRICE TARGET TO 430 (405) PENCE - 'UNDERPERFORM'
----------
UBS RAISES SCHRODERS PRICE TARGET TO 2,800 (2,400) PENCE - 'NEUTRAL'
----------
BERENBERG CUTS GLAXOSMITHKLINE PRICE TARGET TO 1540 (1575) PENCE - 'HOLD'
----------
CITIGROUP RAISES 3I GROUP PRICE TARGET TO 455 (430) PENCE - 'BUY'
----------
S&P CAPITAL IQ CUTS MORRISON TO 'SELL' ('HOLD') - TARGET 155 (195) PENCE
----------
LBBW RAISES ASTRAZENECA PRICE TARGET TO 3900 (3600) PENCE - 'SELL'
----------
NUMIS CUTS HSBC PRICE TARGET TO 700 (725) PENCE - 'ADD'
----------
NUMIS CUTS RANDGOLD RESOURCES PRICE TARGET TO 4,900 (5,100) PENCE - 'BUY'
----------
S&P CAPITAL IQ RAISES ASTRAZENECA PRICE TARGET TO 4700 (4500) PENCE - 'HOLD'
----------
FTSE 250
----------
GOLDMAN CUTS HAYS PRICE TARGET TO 153 (185) PENCE - 'BUY'
----------
TRADERS: GOLDMAN REMOVES HAYS FROM 'CONVICTION BUY LIST' - STILL 'BUY'
----------
GOLDMAN RAISES FIRSTGROUP PRICE TARGET TO 165 (160) PENCE - 'NEUTRAL'
----------
GOLDMAN RAISES BERENDSEN PRICE TARGET TO 1170 (1132) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS MICHAEL PAGE TO 'NEUTRAL' ('BUY') - TARGET 467 (570) PENCE
----------
GOLDMAN CUTS HIKMA PHARMA TO 'NEUTRAL' ('BUY') - TARGET 2120 (2250) PENCE
----------
MORGAN STANLEY RAISES WILLIAM HILL TARGET TO 460 (425) PENCE - 'OVERWEIGHT'
----------
TRADERS: SOCGEN CUTS AVEVA GROUP PRICE TARGET TO 2000 (2250) PENCE - 'BUY'
----------
CHARLES STANLEY RAISES COBHAM TO 'HOLD' ('REDUCE')
----------
BARCLAYS CUTS LONMIN PRICE TARGET TO 190 (205) PENCE - 'UNDERWEIGHT'
----------
BARCLAYS CUTS HALFORDS GROUP PRICE TARGET TO 385 (400) PENCE - 'UNDERWEIGHT'
----------
BARCLAYS CUTS LANCASHIRE HLDGS PRICE TARGET TO 494 (575) PENCE - 'UNDERWEIGHT'
----------
BARCLAYS INITIATES INFINIS ENERGY WITH 'OVERWEIGHT' - TARGET 275 PENCE
----------
TRADERS: JPMORGAN RAISES CRODA PRICE TARGET TO 2,300 (2,250) PENCE - 'NEUTRAL'
----------
HSBC CUTS JD WETHERSPOON PRICE TARGET TO 820 (850) PENCE - 'NEUTRAL'
----------
EXANE BNP CUTS TATE & LYLE PRICE TARGET TO 600 (610) PENCE - 'NEUTRAL'
----------
CITIGROUP RAISES BIG YELLOW GROUP PRICE TARGET TO 540 (470) PENCE - 'NEUTRAL'
----------
CITIGROUP CUTS UBM PRICE TARGET TO 670 (820) PENCE - 'BUY'
----------
CITIGROUP INITIATES POUNDLAND GROUP WITH 'BUY' - TARGET 350 PENCE
----------
TRADERS: JPMORGAN CUTS PLAYTECH TO 'NEUTRAL' ('OVERWEIGHT') - TARGET 615 (860) PENCE
----------
MAIN MARKET AND AIM
----------
CITIGROUP INITIATES B&M WITH 'BUY' - TARGET 310 PENCE
----------
PANMURE RAISES LOOKERS PRICE TARGET TO 175 (166) PENCE - 'BUY'
----------
PANMURE RAISES FILTRONIC PRICE TARGET TO 23 (20) PENCE - 'HOLD'
----------
TRADERS: JPMORGAN CUTS PROMETHEAN TO 'UNDERWEIGHT' ('NEUTRAL')
----------
TRADERS: JPMORGAN RAISES GEM DIAMONDS TARGET TO 280 (270) P - 'OVERWEIGHT'
----------
Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
Today 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
Today 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
Today 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
Today 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
Today 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
Today 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
Today 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
Today 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more
30 Apr 2024 12:22

Sensodyne-maker Haleon to shut UK plant, 435 jobs to go

April 30 (Reuters) - Haleon, the world's largest standalone consumer healthcare firm, will shut its UK production site which makes Sensodyne toothpastes by 2026, leading to 435 job losses, a spokesperson said on Tuesday.

Read more
25 Apr 2024 15:53

GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology

April 25 (Reuters) - GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies' blockbuster COVID-19 vaccines.

Read more
24 Apr 2024 14:19

UK earnings, trading statements calendar - next 7 days

Thursday 25 April 
Aquila European Renewables PLCFull Year Results
Argo Blockchain PLCFull Year Results
AstraZeneca PLCQ1 Results
Barclays PLCQ1 Results
Checkit PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Destiny Pharma PLCFull Year Results
Dillistone Group PLCFull Year Results
Focusrite PLCHalf Year Results
Gem Diamonds LtdTrading Statement
Hikma Pharmaceuticals PLCTrading Statement
Hummingbird Resources PLCTrading Statement
Ibstock PLCTrading Statement
Inchcape PLCTrading Statement
J Sainsbury PLCFull Year Results
London Stock Exchange Group PLCQ1 Results
Persimmon PLCTrading Statement
Pinewood Technologies Group PLCFull Year Results
PPHE Hotel Group LtdTrading Statement
PureTech Health PLCFull Year Results
Relx PLCTrading Statement
Renewi PLCTrading Statement
Schroders PLCQ1 Results
Skillcast Group PLCFull Year Results
Travis Perkins PLCTrading Statement
Trifast PLCTrading Statement
Unilever PLCQ1 Results
WAG Payment Solutions PLCTrading Statement
Weir Group PLCTrading Statement
WH Smith PLCHalf Year Results
WPP PLCTrading Statement
Zinc Media Group PLCFull Year Results
Friday 26 April 
Facilities by ADF PLCFull Year Results
Kingspan Group PLCTrading Statement
Loungers PLCTrading Statement
NatWest Group PLC Q1 Results
Pearson PLCTrading Statement
Record PLCTrading Statement
Smurfit Kappa Group PLCTrading Statement
Taylor Maritime Investments LtdTrading Statement
Monday 29 April 
Beazley PLCTrading Statement
Biome Technologies PLCFull Year Results
Christie Group PLCFull Year Results
Gresham House Energy Storage Fund PLCFull Year Results
Gresham Technologies PLCFull Year Results
Jadestone Energy PLCFull Year Results
Oxford BioMedica PLCFull Year Results
SpaceandPeople PLCFull Year Results
Tuesday 30 April 
Avacta Group PLCFull Year Results
Card Factory PLCFull Year Results
Capital & Regional PLCFull Year Results
Close Brothers Group PLCTrading Statement
Coca-Cola HBC AGTrading Statement
Elementis PLCTrading Statement
essensys PLCHalf Year Results
Fadel Partners IncFull Year Results
Glencore PLCTrading Statement
Hargreaves Lansdown PLC Trading Statement
Howden Joinery PLCTrading Statement
HSBC Holdings PLCQ1 Results
Kelso Group PLCFull Year Results
Northcoders Group PLCFull Year Results
Phoenix Spree Deutschland LtdFull Year Results
RBG Holdings PLCFull Year Results
Rotork PLCTrading Statement
Safestore Holdings PLCHalf Year Results
Shield Therapeutics PLCFull Year Results
St James's Place PLCTrading Statement
Strip Tinning Holdings PLCFull Year Results
Whitbread PLCFull Year Results
Wednesday 1 May 
Computacenter PLCTrading Statement
GSK PLCQ1 Results
Haleon PLCTrading Statement
HSS Hire Group PLCFull Year Results
Intelligent Ultrasound Group PLCFull Year Results
Maintel Holdings PLCFull Year Results
Next PLCTrading Statement
Smith & Nephew PLCTrading Statement
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
24 Apr 2024 09:21

GSK's endometrial cancer drug receives FDA approval

(Sharecast News) - Drugmaker GSK said on Wednesday that the US Food and Drug Administration has accepted a supplemental Biologics License Application for Jemperli, its drug aimed at treating endometrial cancer.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.